Jim Tananbaum is the current, a healthcare private equity firm. Jim is also a founding member of GelTex Pharmaceuticals and Theravance, Inc. which are some of the frontrunners in the biopharmaceutical industry. He draws his investment experience from his founding role in the Prospect Venture Partners II and III and his partnership with the Sierra Ventures at the beginning of his career.
Various investments some of which include Amira Pharmaceuticals, Amerigroup, Healtheon and Jazz Pharmaceuticals have had a taste of Jim Tananbaum’s leadership. He architected Foresite Capital in 2011 as a way of bringing together all the aspects of his career with the aim of creating a new investment platform. This company has been in the forefront in identifying the upcoming healthcare leaders and then helping them to mature to profitability by availing to them capital, information, and networks.
According to INC42, the educational background of Jim Tananbaum is also a rich one and his success in the field of investment can be attributed to this. He was a math and computer science/electric engineering major at Yale. He has an M.B.A from Harvard and an M.S from Massachusetts Institute of Technology. Jim hopes to bring in great change and foster growth by championing insights in science and learning.
Jim Tananbaum and his professional life
The industry experience of Jim Tananbaum is well over 25 years. He commenced his career by being part of Sierra Ventures and Prospect Venture Partners II and III. Some of his major investments include Healtheon, Jazz Pharmaceuticals, Amerigroup and Amira Pharmaceuticals. He holds MD from Harvard Medical School, BS, and B.S.E.E. both from Yale University, MBA from Harvard Business School and MS from MIT.
According to Biz Journals, currently, he holds the position of a CEO at Foresite Capital, a company that he is also the founder. Since it was founded in 2011, Foresite has been steadfast in identifying the upcoming health care leaders and nurturing them to profitability by supplying them with the capital, networks as well as information. In other fields, Dr. Tananbaum has also been part of the advisory board to the Harvard-MIT HST program as well Yale School of Engineering.